The reversal of experimental cardiac arrhythmias by indoramin (Wy 21901).
D000577:Amides / Q000627:therapeutic use; D000779:Anesthetics, Local / Q000494:pharmacology; D000818:Animals; D001146:Arrhythmia, Sinus / Q000188:drug therapy; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy*; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D004837:Epinephrine; D005260:Female; D006168:Guinea Pigs; D006221:Halothane; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D007211:Indoles / Q000627:therapeutic use*; D008012:Lidocaine / Q000494:pharmacology / Q000627:therapeutic use; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009538:Nicotine / Q000494:pharmacology; D010042:Ouabain; D010880:Piperidines / Q000627:therapeutic use; D011343:Procaine / Q000494:pharmacology; D011433:Propranolol / Q000627:therapeutic use; D011802:Quinidine / Q000494:pharmacology; D013610:Tachycardia / Q000188:drug therapy; D014693:Ventricular Fibrillation / Q000188:drug therapy
D000577:Amides; D000779:Anesthetics, Local; D007211:Indoles; D010880:Piperidines; D011343:Procaine; D010042:Ouabain; D009538:Nicotine; D008012:Lidocaine; D011433:Propranolol; D011802:Quinidine; D006221:Halothane; D004837:Epinephrine